<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04921319</url>
  </required_header>
  <id_info>
    <org_study_id>1694487-1</org_study_id>
    <nct_id>NCT04921319</nct_id>
  </id_info>
  <brief_title>De-resuscitation Informed by Ultrasound for Patients With Sepsis</brief_title>
  <acronym>DRI-US</acronym>
  <official_title>Optimizing Fluid Management Informed by Ultrasound for Patients With Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Miriam Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, unblinded clinical trial of 152 critically ill patients with sepsis admitted to&#xD;
      the intensive care unit. The primary determine if using the Venous Excess Ultrasound Score&#xD;
      (VExUS) to guide fluid deresuscitation in critically ill patients with sepsis reduces net&#xD;
      fluid balance at 5 days as compared to usual care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Physicians can assess venous congestions with point of care ultrasound of intraabdominal&#xD;
      veins using the venous excess in ultrasound score (VExUS), which has been shown to predict&#xD;
      the harmful effects of volume overload. We seek to determine if VExUS-guided deresuscitation&#xD;
      reduces the fluid balance in critically ill patients with sepsis as compared to usual care.&#xD;
      This score compiles findings from the inferior vena cava, hepatic vein Doppler waveform,&#xD;
      portal vein Doppler waveform, and intrarenal vein Doppler waveform:&#xD;
&#xD;
      Grade 0: IVC &lt; 2cm, normal pattern in flow patterns of hepatic, portal, and intrarenal veins&#xD;
      Grade 1: IVC ≥ 2cm, normal patterns or mild abnormalities in flow patterns of hepatic,&#xD;
      portal, and intrarenal veins.&#xD;
&#xD;
      Grade 2: IVC ≥ 2cm, severe venous flow pattern in one among hepatic, portal, and intrarenal&#xD;
      veins.&#xD;
&#xD;
      Grade 3: IVC ≥ 2cm, severe venous flow pattern in multiple among hepatic, portal, and&#xD;
      intrarenal veins.&#xD;
&#xD;
      After informed consent, subjects will be randomized in a 1:1 ratio to the VExUS-guided&#xD;
      intervention arm vs control arm. Subjects in both arms will undergo daily ultrasound, and the&#xD;
      investigator will calculate the VExUS immediately after ultrasounds are obtained.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 26, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, unblinded clinical trial of 152 critically ill patients with sepsis admitted to the intensive care unit.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Fluid Balance at 5 days post ICU discharge or ICU Discharge</measure>
    <time_frame>At 5 days post ICU admission or ICU discharge, whichever comes first</time_frame>
    <description>Total fluid balance (ins minus outs)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Acute Kidney Injury</measure>
    <time_frame>At 5 days post ICU admission or ICU discharge, whichever comes first</time_frame>
    <description>acute kidney injury as defined by KDIGO criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of respiratory failure</measure>
    <time_frame>At 5 days post ICU admission or ICU discharge, whichever comes first</time_frame>
    <description>Incidence of respiratory failure defined by intubation rates, ventilator free days, ventilator days, use of non-invasive positive pressure ventilation, and use of high flow oxygen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SOFA score</measure>
    <time_frame>At 5 days post ICU admission or ICU discharge, whichever comes first</time_frame>
    <description>Change in Sequential Organ Failure Assessment (SOFA) score during study period, on scale of 0-48, with higher values being a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day and in-hospital mortality</measure>
    <time_frame>28 days and during hospital admission up to 24 weeks</time_frame>
    <description>All-cause mortality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU discharge fluid balance</measure>
    <time_frame>From ICU admission to ICU discharge or 30 days after ICU admission, whichever comes first</time_frame>
    <description>Cumulative admission fluid balance at time of ICU discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily Sonographic B Line Measurement</measure>
    <time_frame>study enrollment to ICU discharge or 5 days post-enrollment, whichever comes first</time_frame>
    <description>Measured by counting sonographic B lines in 16 lung zones</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Sepsis, Severe</condition>
  <condition>Volume Overload</condition>
  <arm_group>
    <arm_group_label>VExUS-Guided Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive 24 hour fluid balance target based on daily VExUS score.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Control Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Treating team will be blinded to results of daily VExUS score and will set 24 hour fluid balance target based on usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>VExUS score</intervention_name>
    <description>The care team will be informed of the VExUS immediately after the ultrasound is performed and given a suggested target for the following 24 hours as follows:&#xD;
VExUS 0: &quot;The patient will likely tolerate more fluid if clinically needed.&quot;&#xD;
VExUS 1: &quot;The patient has evidence of mild venous congestion. The investigators recommend targeting a net neutral or negative fluid balance with diuresis.&quot;&#xD;
VExUS 2-3: &quot;The patient has evidence of moderate to severe venous congestion. The investigators recommend targeting a fluid balance of negative 1-2L with diuresis.&quot; If the investigator cannot obtain ultrasound images of sufficient quality to calculate VExUS, the care team will be informed that there is no recommendation for that subject on that day.</description>
    <arm_group_label>VExUS-Guided Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. Must be suspected by the treating physician to have sepsis as the primary cause of&#xD;
             their acute illness as exhibited by 2 or more of the following Systemic Inflammatory&#xD;
             Response Syndrome (SIRS) criteria:&#xD;
&#xD;
               1. Temperature of &gt; 38 C or &lt; 36 C&#xD;
&#xD;
               2. Heart rate of &gt; 90/min&#xD;
&#xD;
               3. Respiratory rate of &gt; 20/min or PaCO2 &lt; 32 mm Hg&#xD;
&#xD;
               4. White blood cell count &gt; 12000/mm3 or &lt; 4000/mm3 or &gt;10% immature bands. 2. Known&#xD;
                  or suspected infection at the time of screening 3. Admission to the ICU for &lt;24&#xD;
                  hours&#xD;
&#xD;
        Since approximately 12% of patients ultimately diagnosed with sepsis do not meet SIRS&#xD;
        criteria, SIRS negative patients will be eligible for the study if the treating physician&#xD;
        makes a clinical diagnosis of severe sepsis or septic shock.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with conditions that may interfere with portal Doppler assessments such as&#xD;
             cirrhosis or portal thrombosis&#xD;
&#xD;
          2. Patients with severe chronic kidney disease (estimated glomerular filtration rate&lt;15&#xD;
             mL/min per 1.73 m2 calculated using the Modified Diet in Renal Disease formula).&#xD;
&#xD;
          3. Age &lt; 18 years&#xD;
&#xD;
          4. Active atrial fibrillation or atrial flutter&#xD;
&#xD;
          5. Hemodynamic instability due to active hemorrhage&#xD;
&#xD;
          6. Acute cerebral vascular event&#xD;
&#xD;
          7. Acute coronary syndrome (excluding elevated troponin thought to be from demand&#xD;
             ischemia)&#xD;
&#xD;
          8. Acute pulmonary edema&#xD;
&#xD;
          9. Status asthmaticus&#xD;
&#xD;
         10. Drug overdose&#xD;
&#xD;
         11. Injury from burn or trauma&#xD;
&#xD;
         12. Status epilepticus&#xD;
&#xD;
         13. Indication for immediate surgery&#xD;
&#xD;
         14. Received CPR within 24 hours of enrollment&#xD;
&#xD;
         15. Pregnancy&#xD;
&#xD;
         16. Incarceration.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Corl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rhode Island Hospital / The Miriam Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher F Allison, MD</last_name>
    <phone>401-793-4501</phone>
    <email>callison@lifespan.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Corl, MD</last_name>
      <email>keith_corl@brown.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Beaubien-Souligny W, Rola P, Haycock K, Bouchard J, Lamarche Y, Spiegel R, Denault AY. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound grading system. Ultrasound J. 2020 Apr 9;12(1):16. doi: 10.1186/s13089-020-00163-w.</citation>
    <PMID>32270297</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>June 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

